RYTM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $20,101,832.86

Rhythm Pharmaceuticals Insider Trading History Chart

Rhythm Pharmaceuticals Share Price & Price History

^$62.16

▲ +0.42 (0.68%)

As of 04/21/2025 01:40 PM ET

Days: 30 | 90 | 365

Rhythm Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/8/2025	Pamela J. Cramer	Insider	Sell	20,760	$60.14	$1,248,506.40	19,209
4/8/2025	Yann Mazabraud	EVP	Sell	17,750	$60.99	$1,082,572.50	22,620
3/21/2025	Christopher Paul German	CAO	Sell	344	$54.23	$18,655.12	2,889
3/14/2025	Yann Mazabraud	EVP	Sell	75,000	$51.48	$3,861,000.00	40,370
2/19/2025	Christopher Paul German	CAO	Sell	635	$57.22	$36,334.70	2,070
2/19/2025	David P. Meeker	CEO	Sell	9,896	$57.22	$566,249.12	201,281
2/19/2025	Hunter C. Smith	CFO	Sell	2,215	$57.22	$126,742.30	109,929
2/19/2025	Jennifer Kayden Lee	EVP	Sell	2,035	$57.22	$116,442.70	5,858
2/19/2025	Joseph Shulman	Insider	Sell	1,228	$57.22	$70,266.16	8,509
2/12/2025	Jennifer Kayden Lee	EVP	Sell	1,815	$56.39	$102,347.85	3,598
2/11/2025	Hunter C. Smith	CFO	Sell	1,296	$57.51	$74,532.96	106,295
2/11/2025	Joseph Shulman	Insider	Sell	794	$57.51	$45,662.94	6
2/10/2025	Jennifer Kayden Lee	EVP	Sell	4,189	$58.91	$246,773.99	4,409
2/4/2025	David P. Meeker	CEO	Sell	4,278	$59.43	$254,241.54	189,927
2/4/2025	Hunter C. Smith	CFO	Sell	1,678	$59.43	$99,723.54	101,186
2/4/2025	Jennifer Kayden Lee	EVP	Sell	1,447	$59.43	$85,995.21	4,038
2/4/2025	Joseph Shulman	Insider	Sell	1,281	$59.43	$76,129.83	2,657
11/11/2024	Jennifer Kayden Lee	EVP	Sell	66,861	$66.33	$4,434,890.13	972
11/11/2024	Joseph Shulman	insider	Sell	13,281	$66.44	$882,389.64
11/7/2024	Pamela J. Cramer	Insider	Sell	4,688	$65.00	$304,720.00	13,500
9/17/2024	Jennifer L. Good	Director	Sell	31,751	$52.40	$1,663,752.40	3,000
9/10/2024	Lynn A. Tetrault	Director	Sell	17,501	$49.65	$868,924.65	3,000
9/9/2024	Pamela J. Cramer	Insider	Sell	4,099	$50.03	$205,072.97	13,500
8/26/2024	Lynn A. Tetrault	Director	Sell	4,300	$50.01	$215,043.00	3,000
8/26/2024	Pamela J. Cramer	Insider	Sell	3,200	$50.01	$160,032.00	13,500
8/9/2024	Pamela J. Cramer	Insider	Sell	49,006	$45.15	$2,212,620.90	13,500
7/29/2024	Pamela J. Cramer	Insider	Sell	1,395	$49.06	$68,438.70	31,735
7/16/2024	Joseph Shulman	Insider	Sell	10,468	$53.00	$554,804.00	30
7/12/2024	Joseph Shulman	Insider	Sell	5,313	$50.01	$265,703.13	30
5/9/2024	Joseph Shulman	Insider	Sell	3,984	$38.47	$153,264.48	30
4/2/2024	Christopher Paul German	CAO	Sell	368	$41.76	$15,367.68	795
3/21/2024	Joseph Shulman	Insider	Sell	18,235	$40.34	$735,599.90	30
3/19/2024	David P. Meeker	CEO	Sell	45,494	$39.22	$1,784,274.68	174,605
3/19/2024	Hunter C. Smith	CFO	Sell	15,515	$39.22	$608,498.30	97,939
3/19/2024	Yann Mazabraud	EVP	Sell	16,000	$39.22	$627,520.00	24,495
2/14/2024	Joseph Shulman	Insider	Sell	1,089	$50.01	$54,460.89	30
2/12/2024	Hunter C. Smith	CFO	Sell	1,209	$51.38	$62,118.42	80,413
2/12/2024	Joseph Shulman	Insider	Sell	791	$51.38	$40,641.58	3,457
2/12/2024	Yann Mazabraud	EVP	Sell	1,594	$51.38	$81,899.72	7,702
2/9/2024	Joseph Shulman	Insider	Sell	71,774	$50.38	$3,615,974.12	2,686
12/27/2023	Joseph Shulman	Insider	Sell	5,015	$50.01	$250,800.15	1,126
12/5/2023	Hunter C. Smith	CFO	Sell	7,026	$35.06	$246,331.56	61,406
11/24/2023	Hunter C. Smith	CFO	Sell	10,974	$35.02	$384,309.48	61,406
11/8/2023	Jennifer Kayden Lee	EVP	Sell	5,712	$28.90	$165,076.80	1,647
11/3/2023	Jennifer Kayden Lee	EVP	Sell	80	$28.00	$2,240.00	1,647
9/5/2023	Jennifer Kayden Lee	EVP	Sell	6,166	$28.05	$172,956.30	1,647
8/9/2023	Jennifer Kayden Lee	EVP	Sell	1,718	$24.66	$42,365.88	3,294
8/7/2023	Jennifer Kayden Lee	EVP	Sell	11,223	$24.18	$271,372.14	3,294
7/26/2023	Pamela J. Cramer	Insider	Sell	930	$17.64	$16,405.20	8,418
3/29/2023	William T Roberts	CAO	Sell	912	$17.50	$15,960.00	7,872
2/14/2023	Hunter C. Smith	CFO	Sell	702	$26.87	$18,862.74	59,406
2/14/2023	Jennifer Chien	EVP	Sell	635	$26.87	$17,062.45	4,940
2/14/2023	Joseph Shulman	Insider	Sell	554	$26.87	$14,885.98	3,741
2/9/2023	Hunter C. Smith	CFO	Sell	1,398	$27.66	$38,668.68	57,779
2/9/2023	Jennifer Chien	EVP	Sell	1,192	$27.66	$32,970.72	3,556
2/9/2023	Pamela J. Cramer	Insider	Sell	834	$27.66	$23,068.44	6,151
2/9/2023	William T Roberts	CAO	Sell	959	$27.66	$26,525.94	6,294
8/19/2022	Pamela J. Cramer	Insider	Sell	13,493	$24.83	$335,031.19	2,224
7/27/2022	Pamela J. Cramer	Insider	Sell	901	$11.68	$10,523.68	2,224
7/1/2022	Hunter C. Smith	CFO	Sell	7,547	$4.08	$30,791.76	57,614

See Full Table

SEC Filings (Institutional Ownership Changes) for Rhythm Pharmaceuticals (NASDAQ:RYTM)

Institutional Buying and Selling by Quarter

Rhythm Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2025	Exchange Traded Concepts LLC	11,912	$0.63M	0.0%	-3.7%	0.019%
4/15/2025	Assenagon Asset Management S.A.	22,192	$1.18M	0.0%	N/A	0.035%
4/15/2025	SG Americas Securities LLC	19,667	$1.04M	0.0%	N/A	0.031%
4/14/2025	Harbor Capital Advisors Inc.	77,297	$4.09M	0.2%	+155.5%	0.122%
4/14/2025	Wedge Capital Management L L P NC	36,984	$1.96M	0.0%	-23.6%	0.058%
4/10/2025	Hennion & Walsh Asset Management Inc.	89,622	$4.75M	0.2%	-9.9%	0.142%
4/8/2025	Rhumbline Advisers	85,719	$4.54M	0.0%	+3.6%	0.136%
4/7/2025	GAMMA Investing LLC	14,885	$0.79M	0.0%	+7,305.5%	0.024%
3/24/2025	Wellington Management Group LLP	25,555	$1.43M	0.0%	-7.8%	0.040%
3/18/2025	California State Teachers Retirement System	43,533	$2.44M	0.0%	-0.9%	0.069%
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	76,084	$4.26M	0.0%	N/A	0.124%
2/19/2025	GF Fund Management CO. LTD.	1,290	$72K	0.0%	N/A	0.002%
2/18/2025	Castleark Management LLC	18,390	$1.03M	0.0%	-4.5%	0.030%
2/18/2025	Frazier Life Sciences Management L.P.	1,869,808	$104.67M	4.3%	-22.6%	3.042%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	218,544	$12.23M	0.0%	-3.0%	0.356%
2/17/2025	Voloridge Investment Management LLC	380,537	$21.30M	0.1%	+7.7%	0.619%
2/17/2025	Two Sigma Advisers LP	13,100	$0.73M	0.0%	+2.3%	0.021%
2/17/2025	State of Wyoming	1,084	$61K	0.0%	N/A	0.002%
2/17/2025	Stempoint Capital LP	208,016	$11.65M	2.9%	+404.1%	0.338%
2/17/2025	Rafferty Asset Management LLC	50,394	$2.82M	0.0%	-22.0%	0.082%
2/17/2025	ProShare Advisors LLC	18,328	$1.03M	0.0%	+31.3%	0.030%
2/17/2025	Nuveen Asset Management LLC	146,903	$8.22M	0.0%	-0.7%	0.239%
2/17/2025	OMERS ADMINISTRATION Corp	7,600	$0.43M	0.0%	N/A	0.012%
2/17/2025	Orbimed Advisors LLC	400,000	$22.39M	0.5%	-8.2%	0.651%
2/17/2025	Millennium Management LLC	15,259	$0.85M	0.0%	-58.7%	0.025%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	33,156	$1.86M	0.0%	+2.0%	0.054%
2/17/2025	Lazard Asset Management LLC	106,261	$5.95M	0.0%	N/A	0.173%
2/17/2025	Integral Health Asset Management LLC	150,000	$8.40M	0.7%	N/A	0.244%
2/17/2025	Janus Henderson Group PLC	1,219,554	$68.31M	0.0%	+103.9%	1.984%
2/17/2025	Gotham Asset Management LLC	6,786	$0.38M	0.0%	-28.3%	0.011%
2/17/2025	D. E. Shaw & Co. Inc.	48,198	$2.70M	0.0%	+1,022.4%	0.078%
2/17/2025	Deutsche Bank AG	48,745	$2.73M	0.0%	+46.5%	0.079%
2/17/2025	Driehaus Capital Management LLC	1,290,975	$72.27M	0.6%	-0.7%	2.101%
2/17/2025	Crestline Management LP	25,062	$1.40M	0.0%	+31.9%	0.041%
2/17/2025	Bridgefront Capital LLC	4,604	$0.26M	0.1%	N/A	0.007%
2/17/2025	Baker BROS. Advisors LP	6,084,249	$340.60M	3.6%	-4.9%	9.900%
2/17/2025	Balyasny Asset Management L.P.	138,363	$7.75M	0.0%	N/A	0.225%
2/17/2025	Bellevue Group AG	23,596	$1.32M	0.0%	+50.3%	0.038%
2/17/2025	BNP Paribas Financial Markets	85,249	$4.77M	0.0%	+491.0%	0.139%
2/17/2025	Ameriprise Financial Inc.	53,367	$2.99M	0.0%	+27.4%	0.087%
2/17/2025	Algert Global LLC	41,551	$2.33M	0.1%	-23.3%	0.068%
2/14/2025	Comerica Bank	17,113	$0.96M	0.0%	-2.5%	0.028%
2/14/2025	PDT Partners LLC	43,583	$2.44M	0.2%	+279.0%	0.071%
2/14/2025	Schonfeld Strategic Advisors LLC	59,700	$3.34M	0.0%	+95.5%	0.097%
2/14/2025	Northern Trust Corp	545,314	$30.53M	0.0%	+9.4%	0.887%
2/14/2025	The Manufacturers Life Insurance Company	59,969	$3.36M	0.0%	+23.1%	0.098%
2/14/2025	Tudor Investment Corp ET AL	15,245	$0.85M	0.0%	N/A	0.025%
2/14/2025	Artia Global Partners LP	50,000	$2.80M	1.0%	N/A	0.081%
2/14/2025	Aquatic Capital Management LLC	9,223	$0.52M	0.0%	N/A	0.015%
2/14/2025	Virtus ETF Advisers LLC	6,280	$0.35M	0.1%	-15.4%	0.010%
2/14/2025	Lord Abbett & CO. LLC	160,651	$8.99M	0.0%	+56.5%	0.261%
2/14/2025	Voya Investment Management LLC	97,169	$5.44M	0.0%	-5.5%	0.158%
2/14/2025	Hood River Capital Management LLC	643,691	$36.03M	0.5%	+4.7%	1.047%
2/14/2025	Price T Rowe Associates Inc. MD	685,152	$38.36M	0.0%	+24.5%	1.115%
2/14/2025	Dark Forest Capital Management LP	5,211	$0.29M	0.0%	N/A	0.008%
2/14/2025	Silverarc Capital Management LLC	273,896	$15.33M	3.4%	+7.2%	0.446%
2/14/2025	Diadema Partners LP	75,000	$4.20M	1.8%	N/A	0.122%
2/14/2025	Hsbc Holdings PLC	16,287	$0.92M	0.0%	N/A	0.027%
2/14/2025	Rock Springs Capital Management LP	1,162,718	$65.09M	2.5%	-5.3%	1.892%
2/14/2025	Stifel Financial Corp	19,516	$1.09M	0.0%	-1.6%	0.032%
2/14/2025	Tower Research Capital LLC TRC	4,539	$0.25M	0.0%	+1,100.8%	0.007%
2/14/2025	MetLife Investment Management LLC	33,498	$1.88M	0.0%	+5.8%	0.055%
2/14/2025	Natixis	997	$56K	0.0%	-91.1%	0.002%
2/14/2025	First Trust Advisors LP	118,337	$6.63M	0.0%	+67.2%	0.193%
2/13/2025	Farringdon Capital Ltd.	6,854	$0.38M	0.2%	N/A	0.011%
2/13/2025	Marshall Wace LLP	692,803	$38.78M	0.0%	+70.4%	1.127%
2/13/2025	EAM Global Investors LLC	56,936	$3.19M	0.6%	N/A	0.093%
2/13/2025	EAM Investors LLC	63,078	$3.53M	0.5%	N/A	0.103%
2/13/2025	Walleye Capital LLC	144,342	$8.08M	0.0%	N/A	0.235%
2/13/2025	XTX Topco Ltd	7,605	$0.43M	0.0%	N/A	0.012%
2/13/2025	Mariner LLC	4,525	$0.25M	0.0%	N/A	0.007%
2/13/2025	Barclays PLC	135,397	$7.58M	0.0%	+27.3%	0.220%
2/13/2025	Raymond James Financial Inc.	3,892	$0.22M	0.0%	N/A	0.006%
2/13/2025	Legal & General Group Plc	51,803	$2.90M	0.0%	-7.6%	0.084%
2/13/2025	Invesco Ltd.	302,846	$16.95M	0.0%	+14.5%	0.493%
2/13/2025	ADAR1 Capital Management LLC	30,941	$1.73M	0.3%	N/A	0.050%
2/13/2025	Federated Hermes Inc.	1,549,635	$86.75M	0.2%	-6.9%	2.521%
2/13/2025	Wells Fargo & Company MN	37,324	$2.09M	0.0%	+26.6%	0.061%
2/12/2025	Cinctive Capital Management LP	82,755	$4.63M	0.2%	N/A	0.135%
2/12/2025	Bryce Point Capital LLC	19,607	$1.10M	0.3%	N/A	0.032%
2/12/2025	Trexquant Investment LP	7,798	$0.44M	0.0%	N/A	0.013%
2/12/2025	Geode Capital Management LLC	1,255,799	$70.32M	0.0%	0.0%	2.043%
2/12/2025	Franklin Resources Inc.	268,205	$15.01M	0.0%	+3.4%	0.436%
2/12/2025	Alliancebernstein L.P.	61,470	$3.44M	0.0%	+3.2%	0.100%
2/12/2025	Wellington Management Group LLP	25,555	$1.43M	0.0%	-7.8%	0.042%
2/12/2025	Pictet Asset Management Holding SA	375,349	$21.01M	0.0%	+14.0%	0.611%
2/12/2025	Norges Bank	205,649	$11.51M	0.0%	N/A	0.335%
2/12/2025	Loomis Sayles & Co. L P	618,485	$34.62M	3.7%	-2.8%	1.006%
2/12/2025	JPMorgan Chase & Co.	264,585	$14.81M	0.0%	+224.3%	0.430%
2/11/2025	Corebridge Financial Inc.	27,220	$1.52M	0.0%	-7.0%	0.044%
2/11/2025	Vanguard Group Inc.	3,442,600	$192.72M	0.0%	-0.2%	5.601%
2/11/2025	LPL Financial LLC	4,175	$0.23M	0.0%	-50.9%	0.007%
2/11/2025	KLP Kapitalforvaltning AS	9,300	$0.52M	0.0%	N/A	0.015%
2/11/2025	Sei Investments Co.	33,522	$1.88M	0.0%	+15.5%	0.055%
2/11/2025	American Century Companies Inc.	33,766	$1.89M	0.0%	N/A	0.055%
2/11/2025	Whittier Trust Co.	1,760	$99K	0.0%	-12.0%	0.003%
2/11/2025	Teacher Retirement System of Texas	13,586	$0.76M	0.0%	+18.5%	0.022%
2/11/2025	Xponance Inc.	4,168	$0.23M	0.0%	N/A	0.007%
2/10/2025	Primecap Management Co. CA	6,571,190	$367.86M	0.3%	-8.9%	10.692%
2/10/2025	Cibc World Markets Corp	5,123	$0.29M	0.0%	N/A	0.008%

Data available starting January 2016

See Full Table

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $62.16

$60.90

$62.85

50 Day Range

MA: $54.79

$46.95

$62.09

52 Week Range

Now: $62.16

$35.17

$68.58

Volume

156,767 shs

Average Volume

541,084 shs

Market Capitalization

$3.93 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.32

Who are the company insiders with the largest holdings of Rhythm Pharmaceuticals?: Rhythm Pharmaceuticals' top insider shareholders include:
David P Meeker (CEO)
Hunter C Smith (CFO)
Yann Mazabraud (EVP)
Pamela J Cramer (Insider)
Joseph Shulman (Insider)
Jennifer Kayden Lee (EVP)
Jennifer L Good (Director)
Lynn A Tetrault (Director)
Christopher Paul German (CAO)
Learn More about top insider investors at Rhythm Pharmaceuticals.
Who are the major institutional investors of Rhythm Pharmaceuticals?: Rhythm Pharmaceuticals' top institutional shareholders include:
Hennion & Walsh Asset Management Inc. — 0.14%
Rhumbline Advisers — 0.14%
Harbor Capital Advisors Inc. — 0.12%
Wedge Capital Management L L P NC — 0.06%
Assenagon Asset Management S.A. — 0.04%
SG Americas Securities LLC — 0.03%
Learn More about top institutional investors of Rhythm Pharmaceuticals stock.
Which institutional investors are selling Rhythm Pharmaceuticals stock?: Within the last quarter, RYTM stock was sold by these institutional investors:
Wedge Capital Management L L P NC
Hennion & Walsh Asset Management Inc.
Exchange Traded Concepts LLC
Within the last year, company insiders that have sold Rhythm Pharmaceuticals company stock include:
David P Meeker (CEO)
Hunter C Smith (CFO)
Yann Mazabraud (EVP)
Pamela J Cramer (Insider)
Joseph Shulman (Insider)
Jennifer Kayden Lee (EVP)
Jennifer L Good (Director)
Lynn A Tetrault (Director)
Christopher Paul German (CAO)
Learn More investors selling Rhythm Pharmaceuticals stock.
Which institutional investors are buying Rhythm Pharmaceuticals stock?: In the last quarter, RYTM stock was acquired by institutional investors including:
Harbor Capital Advisors Inc.
Assenagon Asset Management S.A.
SG Americas Securities LLC
GAMMA Investing LLC
Rhumbline Advisers